ACBM Stock Chart & Stats
$0.03
$0.00(0.00%)
At close: 4:00 PM EDT
$0.03
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.10
Previous CloseN/A
Volume260.00
Average Volume (3M)0.00
Market Cap
$1.56M
Enterprise Value$1.93M
Total Cash (Recent Filing)$3.65K
Total Debt (Recent Filing)$385.39K
Price to Earnings (P/E)―
Beta11.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding60,042,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)-3.44
Price to Sales (P/S)0.00
P/FCF Ratio-6.79
Enterprise Value/Market Cap1.24
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-9.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Acro Biomedical Co News
ACBM FAQ
What was Acro Biomedical Co Ltd’s price range in the past 12 months?
Acro Biomedical Co Ltd lowest stock price was $0.02 and its highest was $0.10 in the past 12 months.
What is Acro Biomedical Co Ltd’s market cap?
Acro Biomedical Co Ltd’s market cap is $1.56M.
When is Acro Biomedical Co Ltd’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Acro Biomedical Co Ltd’s earnings last quarter?
Acro Biomedical Co Ltd released its earnings results on Feb 15, 2018. The company reported $0.002 earnings per share for the quarter, beating the consensus estimate of N/A by $0.002.
Is Acro Biomedical Co Ltd overvalued?
According to Wall Street analysts Acro Biomedical Co Ltd’s price is currently Overvalued.
Does Acro Biomedical Co Ltd pay dividends?
Acro Biomedical Co Ltd does not currently pay dividends.
What is Acro Biomedical Co Ltd’s EPS estimate?
Acro Biomedical Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acro Biomedical Co Ltd have?
Acro Biomedical Co Ltd has 60,042,000 shares outstanding.
What happened to Acro Biomedical Co Ltd’s price movement after its last earnings report?
Acro Biomedical Co Ltd reported an EPS of $0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Acro Biomedical Co Ltd?
Currently, no hedge funds are holding shares in ACBM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Acro Biomedical Co Ltd
Acro Biomedical Co., Ltd. focuses on the development and commercialization of dietary supplements. The company offers products such as cordycepin and powdered cordyceps, which come from a type of fungus traditionally utilized in Chinese medicinal practices. Originally founded in 2014, the organization was known as Killer Waves Hawaii, Inc. until it rebranded as Acro Biomedical Co., Ltd. in January 2017. Its operations are headquartered in Fishers, Indiana.
Technical Analysis
Collplant Holdings
―
Bone Biologics
―
Creative Medical Technology Holdings
―
Azitra Inc
―
FibroBiologics, Inc.
―